Botanical species · safety record

Eriobotrya japonica

The EFSA Compendium of Botanicals holds 3 constituent measurements and 2 adverse-effect records for Eriobotrya japonica. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Eriobotrya japonica (Thunb.) Lindl.

3Constituent measurements

2Safety records

4Cited sources

196Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 196 licensed products naming Eriobotrya japonica as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA
Fresh

Source material stated

Dried leaf
Flower
Fruit
Leaf
Leaf (processed with honey)
Leaf (stir-baked with honey)
Leaf/Leaves
Whole plant(s)

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Amygdalin	Seed	—	—	Unspecified	No resolvable identifier
Benzaldehyde	Flower	Super-critical gas extraction	—	GC-MS	No resolvable identifier
Oxalic acid	Flower	Super-critical gas extraction	—	GC-MS	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Systemic	—	Leaves	Solvent extraction	House mouse (as animal)	Short-term toxicity	Resolve DOI
Systemic	Cardiovascular / haematological	Seed	—	Animals (as animal)	Case report	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Weber, MA., Garner, M. Cyanide toxicosis in Asian small-clawed otters (Amblonyx cinereus) secondary to ingestion of loquat (Eriobotrya japonica) . Journal of zoo and wildlife medicine, 2002, vol. 33, no. 2, p. 145-146.
Lu, Yan., Lu, Zhou-min., Fan, Mei-li., Bai, Wei-dong. Changes of volatile components during different stages of loquat flowers. Yuanyi xuebao, 2013, vol. 40, no. 11, p. 2245-2254.
Boorsma, W. G. Pharmacological Reports. machine translation . S'lands plantentuin. bulletin de l'institut botanique de buitenzorg nr. 21., 1904, p. 1-36.
Li, Feng., Li, Yijia., Li, Qingxian., Shi, Xianai., Guo, Yanghao. Acute and Subacute Oral Toxicity Evaluation of Eriobotrya japonica Leaf Triterpene Acids in ICR Mice. . Evidence-based complementary and alternative medicine : ecam, 2017, vol. 2017, p. 4837839-4837839. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature